GT
RMD icon

Greenleaf Trust’s ResMed RMD Stock Holding History

Greenleaf Trust’s Portfolio RMD Stock Details RMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$453K Sell
2,325
-149
-6% -$30.9K ﹤0.01% 540
2026
Q1 		$555K Sell
2,474
-109
-4% -$27.2K 0.01% 465
2025
Q4 		$622K Sell
2,583
-332
-11% -$84.9K 0.01% 446
2025
Q3 		$798K Sell
2,915
-50
-2% -$13.7K 0.01% 389
2025
Q2 		$765K Sell
2,965
-341
-10% -$81.3K 0.01% 390
2025
Q1 		$740K Buy
3,306
+260
+9% +$60.7K 0.01% 399
2024
Q4 		$697K Sell
3,046
-222
-7% -$53.5K 0.01% 428
2024
Q3 		$798K Buy
3,268
+172
+6% +$38.4K 0.01% 392
2024
Q2 		$593K Buy
3,096
+81
+3% +$16.4K 0.01% 433
2024
Q1 		$597K Buy
3,015
+39
+1% +$7.15K 0.01% 428
2023
Q4 		$512K Buy
2,976
+1,223
+70% +$188K 0.01% 455
2023
Q3 		$259K Sell
1,753
-632
-26% -$114K ﹤0.01% 628
2023
Q2 		$521K Sell
2,385
-169
-7% -$37.7K 0.01% 442
2023
Q1 		$559K Buy
2,554
+108
+4% +$23.4K 0.01% 413
2022
Q4 		$509K Sell
2,446
-83
-3% -$18.2K 0.01% 441
2022
Q3 		$552K Buy
2,529
+226
+10% +$51.4K 0.01% 372
2022
Q2 		$483K Buy
2,303
+53
+2% +$11.3K 0.01% 401
2022
Q1 		$546K Buy
2,250
+218
+11% +$52.7K 0.01% 389
2021
Q4 		$529K Buy
2,032
+59
+3% +$15.3K 0.01% 405
2021
Q3 		$520K Buy
1,973
+145
+8% +$39.6K 0.01% 378
2021
Q2 		$451K Sell
1,828
-118
-6% -$24.8K 0.01% 425
2021
Q1 		$378K Buy
1,946
+345
+22% +$69.2K 0.01% 469
2020
Q4 		$340K Buy
1,601
+160
+11% +$31.9K ﹤0.01% 423
2020
Q3 		$247K Buy
1,441
+55
+4% +$10.2K ﹤0.01% 464
2020
Q2 		$266K Sell
1,386
-351
-20% -$57.4K ﹤0.01% 433
2020
Q1 		$256K Buy
+1,737
New +$277K 0.01% 370

Other funds holding RMD

Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return
WF
Welch & Forbes Boston, Massachusetts $8.23B AUM 17.62% 1-Year Est. Return
VF
Vest Financial Mclean, Virginia $9.52B AUM 31.6% 1-Year Est. Return
AT
Arbejdsmarkedets Tillaegspension Hilleroed $4.6B AUM
AS
Aware Super Sydney, Australia $7.06B AUM
TIM
Triodos Investment Management Driebergen-Rijsenburg, Netherlands $1.64B AUM 37.98% 1-Year Est. Return
New York State Teachers Retirement System (NYSTRS)
New York State Teachers Retirement System (NYSTRS) Albany, New York $54.2B AUM 43.77% 1-Year Est. Return
WTA
Washington Trust Advisors Wellesley, Massachusetts $1.35B AUM 28.4% 1-Year Est. Return
CISOA
Capital Investment Services of America Milwaukee, Wisconsin $1.02B AUM 3.04% 1-Year Est. Return

Greenleaf Trust's RMD Position: Q2 2026 in Review

Greenleaf Trust reduced its ResMed (RMD) stake by 6% in Q2 2026, selling an estimated $30.9K and leaving 2,325 shares worth $453K. The position accounts for ﹤0.01% of the portfolio, ranked #540.

Greenleaf Trust first reported a position in RMD in Q1 2020 and has held it in 26 quarters since. The position peaked at $798K in Q3 2025. 301 funds tracked by Wall St. Rank hold RMD as of Q2 2026.

  • Greenleaf Trust held 2,325 shares of ResMed worth $453K as of Q2 2026.
  • Greenleaf Trust sold 149 ResMed shares in Q2 2026, an estimated $30.9K.
  • ResMed made up ﹤0.01% of Greenleaf Trust's portfolio in Q2 2026, its #540 holding.
  • Greenleaf Trust first reported a position in ResMed in Q1 2020 and has held it in 26 quarters since.
  • Greenleaf Trust's ResMed position peaked at $798K in Q3 2025.
  • 301 funds tracked by Wall St. Rank held ResMed as of Q2 2026.

Based on Greenleaf Trust's 13F filing for Q2 2026, filed 21 Jul 2026.